Topic: Fda

Ozempic, a diabetes medication containing semaglutide, has become a viral weight-loss sensation on TikTok and in Hollywood. Manufacturer Novo Nordisk maintains that the drug is not intended for off-label weight loss, though the FDA allows doctors to prescribe it as they see fit. The hosts note that while the drug is marketed heavily to white women in media, black communities are also being targeted using cultural terms like "sugar" for diabetes.

The segment recalls the 1997 recall of the diet drug Fen-Phen due to fatal heart valve complications. The hosts compare this history to the current Ozempic craze, noting that Pfizer's stock dropped after its own weight-loss pill failed clinical trials. They suggest that American pharmaceutical giants may eventually target Novo Nordisk's market dominance by highlighting safety concerns.

The discussion covers Qnexa, a diet drug that combined a seizure medication with Phentermine (half of the original Fen-Phen). While marketed as a "holy grail" for obesity, medical experts cautioned that drugs cannot replace diet and exercise. The hosts use this as a final example of the cyclical nature of "magic" weight-loss solutions and their inevitable side effects.

The White House is promoting a new "intradermal" injection method for the monkeypox vaccine, which allows one traditional dose to be split into five. By injecting the vaccine just under the top layer of skin rather than into fatty tissue, health officials hope to stretch the limited supply. However, the vaccine manufacturer, Bavarian Nordic, has expressed concerns about the lack of data supporting this delivery method and the potential for increased skin reactions.

Using a hypothetical worker named "Joe Katz," the hosts question the logic of firing productive remote employees who refuse vaccination. They reference a legal case involving a George Mason University professor who argues that his natural immunity from a prior COVID-19 infection is superior to vaccine-induced immunity. The discussion highlights that CDC and FDA data often acknowledge the strength of natural antibodies, yet mandates rarely provide exemptions for them.

Former FDA Commissioner Scott Gottlieb, now a Pfizer board member, predicted that the Delta wave would be the last major wave of the pandemic. The hosts suggest this timing coincides with the rollout of Pfizer's new oral COVID treatment pill. They argue that the popularity of alternative treatments like Ivermectin forced the pharmaceutical industry to accelerate the release of their own "subscription-style" medication.

During the late 1980s, the FDA was criticized for its lengthy drug approval process while AIDS patients were dying. The hosts discuss the ethics of placebo-controlled trials for terminal illnesses and the rise of "buyers clubs" for unapproved treatments. Dr. Fauci is noted for testifying that he would seek "street" drugs if he were a patient.

Tyler Perry admits he distrusted the vaccine under the Trump administration's "Operation Warp Speed" but felt comfortable once Biden took office. The hosts point out that the science and technology of the vaccine did not change with the administration, highlighting how political tribalism is used to drive medical compliance. They critique the idea that a change in leadership validates the underlying research.

The science behind the placebo effect is examined, noting that the name is Latin for "I shall please." Federal law requires new drugs to outperform placebos in clinical trials, which is often difficult because the mere anticipation of healing can trigger actual physiological immune responses and lower stress hormones in the body.

Dr. Randy Short discusses the forced administration of the contraceptive Depo-Provera to Ethiopian Jewish women in Israel. The conversation shifts to the drug's prevalence in the U.S. black community and the 2004 FDA "black box" warning regarding its severe side effects, including bone density loss and increased HIV susceptibility.